LXRX vs. GERN
Compare and contrast key facts about Lexicon Pharmaceuticals, Inc. (LXRX) and Geron Corporation (GERN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LXRX or GERN.
Correlation
The correlation between LXRX and GERN is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
LXRX vs. GERN - Performance Comparison
Key characteristics
LXRX:
-0.36
GERN:
0.63
LXRX:
0.10
GERN:
2.47
LXRX:
1.01
GERN:
1.28
LXRX:
-0.37
GERN:
0.71
LXRX:
-0.72
GERN:
4.66
LXRX:
51.50%
GERN:
14.83%
LXRX:
102.49%
GERN:
110.22%
LXRX:
-99.80%
GERN:
-98.65%
LXRX:
-99.72%
GERN:
-94.85%
Fundamentals
LXRX:
$266.96M
GERN:
$2.14B
LXRX:
-$0.74
GERN:
-$0.32
LXRX:
-0.14
GERN:
-2.38
LXRX:
$4.53M
GERN:
$29.46M
LXRX:
$4.12M
GERN:
$28.67M
LXRX:
-$155.66M
GERN:
-$138.52M
Returns By Period
In the year-to-date period, LXRX achieves a 25.92% return, which is significantly higher than GERN's -3.95% return. Over the past 10 years, LXRX has underperformed GERN with an annualized return of -17.77%, while GERN has yielded a comparatively higher 0.77% annualized return.
LXRX
25.92%
31.88%
-41.88%
-39.22%
-25.71%
-17.77%
GERN
-3.95%
-13.49%
-25.76%
58.14%
20.01%
0.77%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LXRX vs. GERN — Risk-Adjusted Performance Rank
LXRX
GERN
LXRX vs. GERN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Lexicon Pharmaceuticals, Inc. (LXRX) and Geron Corporation (GERN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LXRX vs. GERN - Dividend Comparison
Neither LXRX nor GERN has paid dividends to shareholders.
Drawdowns
LXRX vs. GERN - Drawdown Comparison
The maximum LXRX drawdown since its inception was -99.80%, roughly equal to the maximum GERN drawdown of -98.65%. Use the drawdown chart below to compare losses from any high point for LXRX and GERN. For additional features, visit the drawdowns tool.
Volatility
LXRX vs. GERN - Volatility Comparison
Lexicon Pharmaceuticals, Inc. (LXRX) has a higher volatility of 36.12% compared to Geron Corporation (GERN) at 11.13%. This indicates that LXRX's price experiences larger fluctuations and is considered to be riskier than GERN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LXRX vs. GERN - Financials Comparison
This section allows you to compare key financial metrics between Lexicon Pharmaceuticals, Inc. and Geron Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities